Percutaneous and Subcutaneous Tibial Nerve Stimulation
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Medical coverage policy governing percutaneous tibial nerve stimulation (PTNS) and subcutaneous/implantable tibial nerve stimulation for treatment of voiding dysfunction, including overactive bladder; applies to Medicare Advantage and Commercial products of Blue Cross Blue Shield - Rhode Island.
No material clinical or coverage changes in this revision.
Coverage Criteria for Tibial Nerve Stimulation
inv-01: Initial PTNS therapy — covered when ALL of the following are met
Covered when ALL of the following are met
inv-02: Maintenance / Relapse Therapy — maintenance or retreatment allowed when ALL of the following are met
Maintenance or retreatment allowed when ALL of the following are met
Only patients who achieve this threshold with the initial course are eligible for retreatment
Maintenance schedules are individualized; typical regimens are every 4–6 weeks
Subcutaneous tibial nerve stimulation delivered by an implantable peripheral neurostimulator system (for example, eCoin) is not covered for all indications for Medicare Advantage Plans and is not medically necessary for Commercial Products. The evidence is insufficient to demonstrate an improvement in net health outcome for conditions including non-neurogenic urinary dysfunction and overactive bladder.
CPT code 0816T (open insertion or replacement of integrated subcutaneous tibial neurostimulation system) is explicitly listed as not covered for Medicare Advantage Plans. Providers should not bill Medicare Advantage for this procedure when seeking reimbursement under BCBSRI Medicare Advantage benefits.
Open insertion or replacement of subcutaneous implantable tibial neurostimulation systems (CPT 0816T) is considered not covered for Medicare Advantage Plans and not medically necessary for Commercial Products. This code is therefore not reimbursable under the policy for implantable subcutaneous tibial neurostimulation.
CPT/HCPCS code 0816T is explicitly listed as not medically necessary for Commercial Products and not covered for Medicare Advantage Plans in this policy's coding section.
Coding and Billing — CPT / HCPCS
| 64566 | Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming |
| 0587T | Percutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerve |
| 0816T | Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (eg, array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve; subcutaneous |
| 64566 | Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming |
| 0587T | Percutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerve |
| 0816T | Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (eg, array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve; subcutaneous |
Provider Requirements and Prior Authorization
Prior authorization required for PTNS (Medicare Advantage); recommended for Commercial
Prior authorization is required for Medicare Advantage plans through BCBSRI’s online/web-based prior authorization tool for participating providers; prior authorization is recommended for Commercial products for CPTs 64566 and 0587T.
Use web-based prior authorization tool for Medicare Advantage when tool criteria apply
When the web-based prior authorization tool criteria apply, prior authorization via that tool is required for Medicare Advantage plans; Commercial products should meet the policy criteria and follow the related prior authorization policy as applicable.
- Use the online/web-based prior authorization tool for Medicare Advantage participating providers.
- Commercial billing should document meeting the policy criteria (see related prior authorization policy).
Conservative therapy required: behavioral therapy and medication trials
Before PTNS is considered reasonable and necessary, the medical record must show failure of symptom-appropriate behavioral therapy and trials of at least two appropriate medications administered for 4–8 weeks each.
- Behavioral therapy: compliant with and failed a trial of symptom-appropriate behavioral therapy of sufficient length to evaluate efficacy.
- Medication trials: compliant with and failed or been unable to tolerate at least two appropriate medications given for 4 to 8 weeks each.
Provider action: follow specialist evaluation and criteria
(No additional actionable provider steps beyond those already listed in the policy.)
Required documentation: specialist evaluation, therapy and medication trials, voiding diary
Medical records must document: an evaluation by an appropriate specialist (usually urologist or urogynecologist), compliance with and failure of behavioral therapy, compliance with and failure or intolerance of at least two appropriate medications (4–8 weeks each), voiding diary demonstrating OAB, and the beneficiary’s willingness to attend in‑office sessions and continue diaries.
- Specialist evaluation and determination of candidacy must be in the chart.
- Voiding diary showing continued findings of overactive bladder syndrome (OBS).
- Documentation of willingness to attend sessions and comply with behavioral therapies.
Document that prior authorization tool or policy criteria were met before billing
Claims must indicate that the criteria in the web-based prior authorization tool (for Medicare Advantage) or the policy criteria (for Commercial products) were met prior to billing covered CPT/HCPCS codes.
Prior authorization via online tool for Medicare Advantage; recommended for Commercial
Prior authorization is required for Medicare Advantage participating providers via the online tool and is recommended for Commercial products for PTNS procedures (CPT 64566 and HCPCS 0587T).
- Use the BCBSRI online/web-based prior authorization tool for Medicare Advantage participating providers.
- Commercial products: follow policy criteria; prior authorization is recommended.
Denial risk if CPT 0816T is billed (not covered / not medically necessary)
CPT 0816T (open insertion or replacement of integrated subcutaneous tibial neurostimulation system) is listed as not covered for Medicare Advantage plans and not medically necessary for Commercial products; billing this code risks claim denial.
Conservative Treatment and Documentation Requirements
inv-28: Must document compliance and failure or intolerance — behavioral therapy duration and medication trials (4–8 weeks each)
Must document compliance and failure or intolerance
Document duration and evidence of compliance in the medical record (e.g., notes, diaries)
Document medication names, doses, duration (4–8 weeks each), and reason for failure or intolerance
Include evidence of behavioral therapy compliance and medication trial details
Treatment Frequency and Maintenance
Imaging When Indicated
Definitions and Procedure Terms
Background and Evidence Summary
Percutaneous tibial nerve stimulation (PTNS) is an electrical neuromodulation technique that delivers low-voltage stimulation to the posterior tibial nerve via a percutaneous needle electrode near the medial malleolus. Typical treatment consists of an initial course of one 30-minute session per week for 12 weeks, followed by individualized maintenance, commonly every 4–6 weeks.
Not Covered Items
NOT COVERED: Subcutaneous/implantable tibial nerve stimulation systems (for example, eCoin) are not covered / not medically necessary for all indications due to insufficient evidence of net health benefit. Additionally, open subcutaneous insertion or replacement (CPT 0816T) is listed as not covered for Medicare Advantage Plans and not medically necessary for Commercial Products.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.